SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Winfastorlose who wrote (1341517)2/7/2022 2:49:26 PM
From: Tenchusatsu  Read Replies (1) | Respond to of 1572025
 
WFoL,
Why would anyone spend 50 to 100 million dollars to do a Phase 1, 2 and 3 study on Vitamin D or HCQ (off patent) or IVM (Off patent)? There is ZERO money in it for pharma.
Not for Vitamin D, but HCQ and Ivermectin can still be sold for $2-$10 per dose.

Given how many antivaxxers are out there in America, let alone the entire world, that revenue can add up.

Tenchusatsu


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News